Delivery Order SPE2DB20D3101-SPE2DB25FRPV3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,495.87 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clindamycin HCL 150 mg capsules (100-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside award. The product will be supplied from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials totaling $1,242.18 under a firm fixed-price arrangement. This non-set-aside competitive award is scheduled for completion by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Clindamycin 150mg tablets in a quantity of 500 units, with a firm fixed price ceiling value of $2,586.72. This is a non-set-aside competitive award executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,049.06 by the Defense Logistics Agency (DLA) for 500 capsules of Clindamycin HCL 150 mg. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was competitively awarded without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,800.64 delivery order to AmerisourceBergen Drug Corp for 100 units of Clindamycin 150mg on July 29, 2025. This competitive delivery order, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical procurement supporting federal military and veteran healthcare operations. The award was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ML units, with a contract value of $5,685.56. This non-competitive delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and is structured as a firm fixed price contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.84 to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 mL in 50 mL vials. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $2,117.43 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRPV3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Clindamycin HCl 300 mg capsules (100-count units) with a ceiling value of $1,200.84. This firm fixed-price delivery order, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills ongoing medical supply needs for military and veteran healthcare systems through its expansive IDC. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to deliver a wide range of pharmaceutical products, including generic and brand-name medications, across multiple therapeutic domains. This particular delivery order for the antibiotic Clindamycin exemplifies the routine pharmaceutical procurement activity executed under the prime vendor framework to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/10/25 |